| 11:45 – 12:30 p.m. | Registration, Check-in, Lunch
|
| 12:40 – 12:45 p.m. | Welcoming Remarks
Dr. Vijaya L. Korlipara
Director, Institute for Biotechnology
|
| 12:45 – 12:50 p.m. | Greetings from the Provost
Julia A. Upton, RSM, Ph.D.
|
| 12:50 – 1 p.m. | Recognition of Dr. Diana Bartelt
Founding Director, Institute for Biotechnology
Dr. Diane Hergenrother
Associate Provost
|
| 1– 1:45 p.m. | “New era of drug discovery for Muscle and Metabolic
Diseases”
Dr. Esther Latres
Senior Fellow, Regeneron Pharmaceuticals Inc., Tarrytown, NY
|
| 1:45 – 2:30 p.m. | “Development of modulators of multidrug
resistance-linked ABC drug transporters”
Dr. Suresh V. Ambudkar
Senior Investigator, Chief, Transport Biochemistry Section,
Laboratory of Cell Biology, CCR, NCI, NIH, Bethesda, MD
|
| 2:30 – 3:15 p.m. | “Engineering Enzymes to Self-Assemble into Catalytic
Biomaterials”
Dr. Scott Banta
Associate Professor, Department of Chemical Engineering, Columbia
University, NY
|
| 3:15 – 3:30 p.m. | Coffee Break
|
| 3:30 – 4:15 p.m. | “Opportunities and Challenges Using Natural Products in
Oncology Drug Discovery”
Dr. Gunda I. Georg
Professor and Department Head, Robert Vince Endowed Chair McKnight
Presidential Chair in Medicinal Chemistry, Department of Medicinal
Chemistry Director, Institute for Therapeutics Discovery and
Development, College of Pharmacy, University of Minnesota, MN
|
| 4:15 – 5 p.m. | “The Discovery of OSI-906 (Linsitinib), a
potent and highly selective dual inhibitor of IGF-1R and IR
currently advancing through clinical trials for the treatment of
cancer”
Dr. Mark Mulvihill
Director of Chemistry, Oncology, OSI Pharmaceuticals LLC, a
subsidiary of Astellas US, 1 Bioscience Park Dr.,
Farmingdale, NY
|
| 5 - 5:05 p.m. | Closing Remarks
Irvin Hirshfield, Ph.D.
Associate Professor, Biological Sciences
|